Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease

<div>(a) Correlation between inflammatory cytokines including IL-17 and IL-23 in both sputum and serum and sputum neutrophil ratios. (b) Correlation between inflammatory cytokines including IL-17 and IL-23 in both sputum and serum and sputum macrophage ratios.</div>

Mediators of Inflammation

fig5

Figure 5

Figure 5: Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease 

Figure 5 | Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease 